Home Capital Broker's Calls

Could investing in this tech incubator become a trend?

Michelle Zhu
Michelle Zhu5/23/2017 01:38 PM GMT+08  • 2 min read
Could investing in this tech incubator become a trend?
SINGAPORE (May 23): CIMB Research has issued an unrated report on Trendlines Group as an “intensely hands-on technology” incubator based in Israel, and as a stock that is currently trading at a discount to its global peers.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

SINGAPORE (May 23): CIMB Research has issued an unrated report on Trendlines Group as an “intensely hands-on technology” incubator based in Israel, and as a stock that is currently trading at a discount to its global peers.

In a Tuesday note, analysts Ngoh Yi Sin and William Tng highlight the incubator’s experienced management team and strong financial backing from Israel’s government, with the group further seeking to add another 8-10 companies to its existing portfolio of 46.

“Management’s relentless efforts to increase overall portfolio value not only involves adding new companies annually and growing its Trendlines Labs, but also expansion into other geographical markets. Trendlines recently set up its first overseas subsidiary in Singapore (76.4%-owned Trendlines Medical Singapore), which adopts a similar investment model, and has clinched a partnership with Singapore General Hospital (SGH) to develop and conduct clinical trials,” say Ngoh and Tng.

×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.